Table 1

Demographic profile and baseline characteristics of two groups

AGV
n (%)
AADI
n (%)
P value
Number of patients173201
Number of eyes189206
Age52.68±16.8447.82±16.79<0.01
 Sex (male:female)135:54145:610.83
 Laterality (right:left)95:9498:1080.62
 Mean cup disc ratio0.76±0.190.76±0.150.18
 Mean visual acuity (logMar)0.62±0.260.68±0.220.03
Mean IOP30.15±11.3129.97±11.030.85
 Preoperative AGM
 Mean combined AGM4.06±1.214.52±0.99<0.01
 Mean topical AGM3.12±1.093.38±0.850.02
 Mean oral AGM0.94±0.391.17±0.56<0.01
Failed GFS42570.58
Lens status
 Phakic70 (37.04)85 (41.26)0.41
 Pseudophakic101 (53.44)99 (48.06)0.31
 Aphakic18 (9.52)22 (10.68)0.74
 Aetiology
Secondary glaucoma
 Post-penetrating keratoplasty18 (9.52%)32 (15.53%)0.09
 NVG20 (10.58%)31 (15.05%)0.23
 Trauma12 (6.35%)27 (13.11%) 0.03
 Post-PPV40 (21.16%)21 (10.19%) < 0.01
 Uveitic8 (4.23%)16 (7.77%)0.21
 Pseudophakic glaucoma7 (3.70%)8 (3.88%)1.00
 ICE6 (3.17%)6 (2.91%)1.00
 PBK5 (2.65%)6 (2.91%)1.00
 Lens induced2 (1.06%)4 (1.94%)0.69
 Steroid6 (3.17%)2 (0.97%)0.16
 Malignant1 (0.53%)1 (0.49%)1.00
Primary glaucoma
 POAG44 (23.28%)30 (14.56%) 0.03
 PACG18 (9.52%)11 (5.34%)0.13
Childhood glaucoma
 JOAG1 (0.53%)6 (2.91%)0.12
 PCG/developmental1 (0.53%)5 (2.43%)0.22
  • AADI, aurolab aqueous drainage implant; AGM, antiglaucoma medication; AGV, Ahmed glaucoma valve; GFS, glaucoma filtration surgery; ICE, iridocorneal endothelial syndrome; IOP, intraocular pressure; JOAG, juvenile open-angle glaucoma; NVG, neovascular glaucoma; PACG, primary angle-closure glaucoma; PBK, pseudophakic bullous keratopathy; PCG, primary congenital glaucoma; POAG, primary open-angle glaucoma; PPV, pars plana vitrectomy; logMar, logarithm of the minimum angle of resolution.